完成时内漏与随访内漏对生存、再干预和破裂的影响
基于血管质量倡议-医疗保险数据库2003至2016年21,745例EVAR患者,分析完成时内漏及14,479例详细随访内漏数据。完成时I型内漏与较低5年生存和免于再干预相关,随访中I型和III型内漏与较低生存相关,任何随访内漏均与较低免于再干预和免于破裂相关。
要点
- 完成时I型内漏较无内漏者5年生存降低(69% vs 75%,P < .001)
- 随访中任何类型内漏均与较低5年免于再干预相关
- 随访中I型内漏与较低5年免于破裂相关(92% vs 94%,P < .001)
核心结论
- 完成时I型内漏患者较无内漏者5年生存和免于再干预更低;随访中I型和III型内漏患者生存更低,任何随访内漏均与较低免于再干预和免于破裂相关。
研究设计与样本
- 回顾性队列研究,纳入血管质量倡议-医疗保险数据库2003至2016年接受EVAR的患者,排除破裂就诊者;完成时内漏数据21,745例,详细随访内漏数据14,479例。
主要发现
- 完成时内漏5,085例(23%);I型内漏5年生存69% vs 无内漏75%(P < .001),II型79%(P < .001),III型73%、IV型73%、不确定型75%无统计学差异。
- 完成时I型和III型内漏免于再干预低于无内漏(I型76%,P < .001;III型72%,P < .001 vs 83%);II型和III型免于破裂高于无内漏(95%和97% vs 94%,P < .001)。
- 随访内漏2,290例(16%);I型和III型5年生存低于无内漏(I型80%,P = .002;III型66%,P < .001 vs 84%),II型82%和不确定型77%无差异。
- 随访任何类型内漏免于再干预低于无内漏(I型70%,P < .001;II型76%,P = .006;III型36%,P < .001;不确定型60%,P = .007 vs 84%)。
- 随访任何类型内漏免于破裂低于无内漏(I型92%,P < .001;II型91%,P = .16;III型88%,P = .01;不确定型90%,P = .11 vs 94%)。
临床怎么用
- 作者认为这些数据强调EVAR后仔细选择患者和密切术后随访的重要性,因内漏尤其I型和III型随时间推移预示更差结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endoleaks may be seen at case completion of endovascular abdominal aortic aneurysm repair (EVAR), and the presence of an endoleak may impact outcomes. However, the clinical implications of various endoleaks seen during follow-up is not well-described. Therefore, we studied the impact of endoleaks at completion and at follow-up on mid-term outcomes. METHODS: We reviewed patients who underwent EVAR from 2003 to 2016 within the Vascular Quality Initiative-Medicare database and identified patients with endoleak at procedure completion and during follow-up, excluding those presenting with rupture. We stratified cohorts by presence of completion and follow-up endoleak subtypes. The primary outcome was 5-year survival, and secondary outcomes included 5-year freedom from reintervention and freedom from rupture. We used Kaplan-Meier estimates and log-rank tests to analyze differences in time-to-event endpoints. RESULTS: Of 21,745 patients with completion endoleak data, 5085 (23%) had an endoleak. Compared with those without endoleak, those with type I endoleaks had lower 5-year survival (69% vs 75%; P < .001), type II endoleaks had higher survival (79%; P < .001), and types III, IV, and indeterminate were not statistically different (73%, 73%, and 75%, respectively). Freedom from reintervention for types I and III endoleaks were significantly lower than no endoleak cohort (I: 76%; P < .001; III: 72%; P < .001 vs 83%), but freedom from rupture was higher for those with type II and III endoleak (95% and 97% vs 94%; P < .001). Of 14,479 patients with detailed follow-up endoleak data, 2290 (16%) had an endoleak. Compared with those without endoleak, types I and III had significantly lower 5-year survival (I: 80%; P = .002; III: 66%; P < .001 vs 84%), but there were no differences for types II (82%) and indeterminate (77%). Those with any type of follow-up endoleak had lower 5-year freedom from reintervention (I: 70%; P < .001; II: 76%; P = .006; III: 36%; P < .001; indeterminate: 60%; P = .007 vs 84%), and lower freedom from rupture (I: 92%; P < .001; II: 91%; P = .16; III: 88%; P = .01; indeterminate: 90%; P = .11 vs 94%). CONCLUSIONS: Compared with patients with no endoleak, those with type I completion endoleaks have lower 5-year survival and freedom from reintervention. Patients with types I and III follow-up endoleaks also have lower survival, and any endoleak at follow-up is associated with lower freedom from reintervention and freedom from rupture. These data highlight the importance of careful patient selection and close postoperative follow-up after EVAR, as the presence of endoleaks, specifically type I and III, over time portends worse outcomes.
引用
- Li C, de Guerre LEVM, Dansey K, et al. The impact of completion and follow-up endoleaks on survival, reintervention, and rupture. J Vasc Surg. 2023. PMID: 36841312. doi:10.1016/j.jvs.2023.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。